NASDAQ · EYEGHealthcarePharmaceuticals

AB Corporate Bond ETF (EYEG)

$33.54−0.67%
Close Nov 12, 2026 · split-adjusted
Nov 11, 2026$33.76▼ 6.48% in range
Nov 11, 2025Low $33.27 · High $36.27Nov 11, 2026
What changed · written from our data
As of Nov 12, 2026

AB Corporate Bond ETF closed at $33.53 on Nov 12, down 0.67%, within 0.8% of its 52-week closing low. Volume of 37 shares was 0.01× its 20-day average (below normal).

Split-adjusted performance: +0.1% over one month, -4.7% over six months, -7.1% over one year.

Short interest was 43 shares at the Oct 30 settlement, down 95.5% from the prior report (1.0 days to cover).

Market cap$26.8M800.0K shares
Revenue · quarter$0.00—
Diluted EPS$-0.34—
P/E · TTM—
Net margin—
Dividend yield5.22%$0.146 last paid
52-week range33.27 – 36.27−7.6% from high
Volume370.01× 20-day avg
Volatility · 60d5.5%Annualised
Short % of float—1.0 days to cover
Net cash$16.8MCash $16.8M
Next earnings—Not scheduled
Split-adjusted performance
1W −1.3%1M +0.1%3M −3.0%6M −4.7%YTD −6.2%1Y −7.1%3Y —5Y +1593.7%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Pharmaceuticals

Percentile among 417 companies (100 = best)

6-month momentum—
Revenue growth—
Net margin—
Value (low P/E)—
Size—

Industry medians: 6-month return −26.3%, revenue growth +9.3%, net margin −35.1%, P/E 16.5×.

Short interest

Details →
Shares short43−95.5% vs prior
Days to cover1.0Settled Oct 30
% of float—
Short vol. 10d7.7%of daily volume

Closest peers by size in Pharmaceuticals

CompanyPriceToday6MRev. growthNet marginP/EMkt cap
EYEGAB Corporate Bond ETF$33.54−0.67%−4.7%———$26.8M
UNOVInnovator U.S. Equity Ultra Buffer ETF - November$41.63−0.12%+4.5%−19.3%11.4%29.7$111.4MCompare

News about AB Corporate Bond ETF

All news →

No recent articles focused on AB Corporate Bond ETF.

Quick answers

What is EYEG's market cap?
$26.83M, based on the Nov 12 close of $33.53.
Does AB Corporate Bond ETF pay a dividend?
Yes. The latest regular dividend was $0.146 per share (ex-date Nov 2), an annualised yield of 5.22%.
What sector is EYEG in?
Healthcare, in the Pharmaceuticals industry.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology